Skip to content

Lukowski Named to North American Quitline Consortium Board of Directors


Amy V. Lukowski, PsyD, clinical director of health initiatives programs at National Jewish Health, has been elected to the North American Quitline Consortium (NAQC) board of directors. The NAQC is an international, non-profit membership organization that seeks to promote evidence-based quitline services across communities in North America.


“I am very excited to be part of the leading organization that supports tobacco cessation quitline services to individuals dependent on tobacco in North America,” said Dr. Lukowski.  “I look forward to serving NAQC in continuing their mission to maximize the access, use, and effectiveness of quitlines.”

Quitlines are telephone-based tobacco-cessation services that help tobacco users quit. Services offered by quitlines include coaching and counseling, referrals, mailed materials, training to healthcare providers, Web-based services and, in some instances, free medications, such as nicotine replacement therapy (NRT).

Research has shown that quitlines are highly effective in helping tobacco users quit. Due to their effectiveness and ability to reach and serve tobacco users, regardless of location, quitlines have spread quickly across North America.

Dr. Lukowski also is an assistant professor of medicine at National Jewish Health, a licensed psychologist, a tobacco treatment specialist (TTS) and a MINT (motivational interviewing network of trainers) trainer.

Currently, she is responsible for the clinical leadership, staff training, and the clinical quality assurance and quality improvement programs for the National Jewish Health Quitlines. National Jewish Health currently operates quitlines for ten states, numerous health care plans and private employers.

National Jewish Health is known worldwide for treatment of patients with respiratory, cardiac, immune and related disorders, and for groundbreaking medical research. Founded in 1899 as a nonprofit hospital, National Jewish Health remains the only facility in the world dedicated exclusively to these disorders. For 15 consecutive years U.S. News & World Report has ranked National Jewish Health the number one respiratory hospital in the nation.

National Jewish Health is the leading respiratory hospital in the nation. Founded 125 years ago as a nonprofit hospital, National Jewish Health today is the only facility in the world dedicated exclusively to groundbreaking medical research and treatment of children and adults with respiratory, cardiac, immune and related disorders. Patients and families come to National Jewish Health from around the world to receive cutting-edge, comprehensive, coordinated care. To learn more, visit the media resources page.

We have many faculty members, from bench scientists to clinicians, who can speak on almost any aspect of respiratory, immune, cardiac and gastrointestinal disease as well as lung cancer and basic immunology.

Our team is available to arrange interviews, discuss events and story ideas.m